Plain-English translation of NCT06609850 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial tests whether adding an ablation procedure (a technique that destroys cancer cells with heat or cold) to a combination of chemotherapy injection and the medication Lenvatinib improves outcomes for people with recurring liver cancer. You would receive one of two treatments: either chemotherapy injected directly into the tumor plus Lenvatinib taken by mouth daily, or the same combination plus an ablation procedure.
When liver cancer comes back after initial treatment, doctors need better ways to help patients live longer and with better quality of life. This study aims to find out whether adding ablation to the standard combination of chemotherapy and this medication might work better than the two treatments alone.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would be randomly assigned to one of two groups. Both groups receive a chemotherapy injection procedure followed by daily oral medication. One group receives only these two treatments, while the other group also receives an ablation procedure to destroy remaining cancer cells. You would be monitored regularly with imaging scans and blood tests to see how well the treatment is working and to watch for any side effects.
AI-generated summary from trial data ยท Jun 25, 2026 ยท Not medical advice
China